Drug-induced lupus associated with infliximab and adalimumab in an adolescent with Crohn disease.
Zella
Garrett C
GC
Department of Pediatrics, Massachusetts General Hospital, Boston, 02114, USA. gzella@partners.org
Weinblatt
Michael E
ME
Winter
Harland S
HS
D000068879:Adalimumab; D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000069285:Infliximab; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced*
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069285:Infliximab; D000068879:Adalimumab